CAPTRUST Financial Advisors’s MIRA Pharmaceuticals MIRA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85.8K	Buy	+90,645	New	+$91.7K	﹤0.01%	3067

Other funds holding MIRA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CSI

Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FAB

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

CAPTRUST Financial Advisors's MIRA Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in MIRA Pharmaceuticals (MIRA) in Q2 2026: 90,645 shares worth $85.8K. The stake represents ﹤0.01% of the portfolio and ranks #3067 among its holdings.

26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

CAPTRUST Financial Advisors held 90,645 shares of MIRA Pharmaceuticals worth $85.8K as of Q2 2026.
MIRA Pharmaceuticals was a new CAPTRUST Financial Advisors position in Q2 2026.
MIRA Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3067 holding.
26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.